
HTG Molecular Diagnostics HTGM
Annual report 2022
added 03-30-2023
HTG Molecular Diagnostics EV/EBITDA Ratio 2011-2026 | HTGM
Annual EV/EBITDA Ratio HTG Molecular Diagnostics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.42 | -1.05 | -1.37 | -4.08 | -2.36 | -0.747 | -1.18 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.747 | -4.08 | -1.74 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 19.5 | 8.76 % | $ 210 M | ||
|
Agilent Technologies
A
|
27.4 | $ 121.0 | 2.98 % | $ 36.8 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.49 | 3.92 % | $ 932 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 516.32 | 3.01 % | $ 14.9 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.85 | 5.77 % | $ 449 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.28 | 3.44 % | $ 1.06 B | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 1.44 | -1.03 % | $ 1.92 M | ||
|
Natera
NTRA
|
-19.5 | $ 213.25 | 5.62 % | $ 21 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 29.14 | 2.07 % | $ 20 B | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 24.43 | 3.82 % | $ 679 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.76 | 0.53 % | $ 282 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 52.62 | -0.04 % | $ 2.67 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 180.06 | 0.96 % | $ 8.92 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 2.2 | - | $ 9.73 M | ||
|
Danaher Corporation
DHR
|
20.1 | $ 198.18 | 1.18 % | $ 141 B | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 526.87 | 2.46 % | $ 199 B | ||
|
Illumina
ILMN
|
70.5 | $ 129.95 | 2.35 % | $ 20.7 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 56.8 | 12.74 % | $ 3.4 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 15.73 | 2.81 % | $ 476 M | ||
|
Guardant Health
GH
|
-28.8 | $ 85.3 | 3.76 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.85 | - | $ 92.5 K | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.1 | 0.96 % | $ 4.82 M | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 112.98 | 2.36 % | $ 9.32 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 267.53 | 1.27 % | $ 22.3 B | ||
|
Celcuity
CELC
|
-2.38 | $ 120.04 | -0.3 % | $ 5.61 B | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.55 | 4.43 % | $ 2.07 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 82.57 | 1.1 % | $ 5.57 B | ||
|
Waters Corporation
WAT
|
24.6 | $ 330.99 | 1.94 % | $ 19.7 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 193.93 | 0.53 % | $ 21.5 B |